PROACTIVE SAFETY, MINIMIZING RISK
April 15–17, 2019 | Philadelphia Convention Center
Sign Up for Event Updates
WELCOME TO WORLD DRUG SAFETY CONGRESS AMERICAS
The World Drug Safety Congress Americas has served as the only commercially focused event for the pharmacovigilance community for over 10 years.
4 TRACKS OF CONTENT
NEXT GEN TECH
PV innovators will explore using technology in safety signal detection & management, global harmonization of PV and showcase breakthroughs in AI
BIG DATA, RISK AND PV
Heads of PV, data and risk will tackle post market authorization, data management, risk in the lifecycle and pharmacoepidemiology
PATIENT CENTRICITY AND MEDICAL DEVICES (NEW)
Medical Directors and Medical Device experts will uncover opportunities to redefine clinical trials around the patient, automate PV, explore safety monitoring devices and microphysiological systems
TOXICOLOGY (NEW)
Pharma and biotech toxicology experts will analyse synthesis of complex protein structures, genomic toxicology screening as well as compliance in toxicology
2018 Keynote Speakers
- Virginia AchaExecutive DirectorAssociation of the British Pharmaceutical Industry-ABPIAnupam AgarwalHead, Global Drug Safety and PharmacovigilanceZogenixVivek AhujaVice President of Global PharmacovigilanceArisGlobal
- Omar AimerPharmacovigilance and drug safety specialistRymond Poincaré Hospital - APHPAnn StraussMerckRawad AntounManufacturing Site Pharmacovigilance RepresentativeCSL Behring
- Felix ArellanoGlobal Head Pharmacovigilance and Drug SafetyRocheQuazi AtaherSenior Director, Epidemiology. Worldwide Safety and RegulatoryPfizerTony BahinskiGlobal Head, Safety PharmacologyGSK
- Greg BallSenior Principal StatisticianMerck & CoKhaudeja BanoSenior Medical DirectorAbbott DiagnosticsFran BatesVice President of Technology ServicesSciformix Corp
- Arvind BellurDirector, Head of Safety Data ManagementSanofiAndrea BestExecutive Medical Director, Pharmacovigilance and Patient SafetyAbbVieMartin BluthFounderBluth Bio Industries
- Mariette BoerstoelSenior Vice-President, Head Global Drug SafetyShire PharmaceuticalsKubra BorgardtDirectorAbbVieNiraj ChhayaLead Risk Management, Global PharmacovigilanceBoehringer Ingelheim Pharma GmbH & Co. KG
- David ChonziVP, Patient Safety and Risk ManagementKite, A Gilead CompanyShaun ComfortAssoc Director of Risk ManagementGenentech A Member of the Roche Group IncPaul CoplanExecutive Director Risk Management and EpidemiologyPurdue Pharmaceutical Products LP
- Wenda BrennanHead of PVPharmaLex GmbHShelly BrewsterPharmacovigilance Operations ManagerIntarcia Therapeutics IncAdrian DanaVice President, Global Patient Safety and Risk ManagementAlnylam Pharmaceuticals
- Bettina DoepnerDirector, Therapeutic Area Lead EU Region Global Regulatory AffairsCSL BehringDebbie DraneSenior Vice President Global Commercial DevelopmentCSL BehringJay DuhigHead, Risk Communication and Behavioral SystemsAbbVie
- Bernard FerminiChief Scientific OfficerCoyne Scientific (Former Pfizer).Essam GhanemHead of Drug Safety and Pharmacovigilance (DSPV)VIGI-CAREShelly GoodmanHead, Global Pharmacovigilance and Drug SafetyPortola Pharmaceuticals , Inc.
- Eric HudimacAssociate DirectorIntarcia Therapeutics IncPriya JainMedical DirectorAlkermesJeremy JokinenSenior Director, Safety Decision AnalyticsAbbVie
- Alexandre KiazandSafety Sciences Global HeadAstraZenecaKostas KidosVP, Head Global Drug Safety OperationsShire PharmaceuticalsBill KivettDirector of Product Management for ProQuest Dialog and Pi2ProQuest
- David J LewisGlobal Head of PharmacovigilanceNovartisFabio LievanoVice President Safety Sciences, Medical Safety EvaluationAbbvie Pharmaceuticals IncAnders LindholmVice President and Head of Drug Safety Therapeutic Area Inflammation and ImmunologyCelgene
- Raj LongDeputy Director, Integrated Development, Global HealthThe Bill & Melinda Gates FoundationMichael LusiolaDirector, Patient SafetyAstraZenecaMike LiuSenior Medical Director, Clinical Safety/PVAbbVie
- Barbara MorolloHead, Pharmacovigilance OperationsModerna TherapeuticsSarah MycroftDirector, Clinical Safety PhysicianCSL BehringWilliam O'BrienChairman of Medical Surveillance Team and Virology, Global Pharmacovigilance and EpidemiologyBristol Myers Squibb
- Mehul PatelKite, A Gilead CompanyKirsten H. PaulsonSr. Director Global CMC-Medical DevicesPfizerAndrew PurchaseAssociate Director, Safety and Risk Management - Global Patient SafetyPRA
- Barbara Silva-TillmannSenior Medical Director, Benefit Risk ManagementAbbVie LtdWalter StrausAssociate Vice-President and Therapeutic Area Head, Infectious Diseases, Vaccines, Medical Devices & Combination ProductsMerck And CompanyMike ThomasMedical Director PharmacovigilanceUnited Therapeutics
- Ed TuckerSVP Clinical Development & Medical SafetyAcertaKevin TynanConsultant, Pv Operations Global Clinical Safety and PharmacovigilanceCSL BehringVeronica UrdanetaSenior Principal Scientist/ PhysicianMerck
- Ale (Maria) Vazquez-GraggVP, Head Global Patient SafetyIntarcia Therapeutics IncJose VegaChief Safety OfficerMerck & Co., Inc.William WangExecutive Director, Clinical Safety StatisticsMSD
- Susan WelshChief Safety OfficerCSL BehringRichard WolfHead of I.C.S.R. Case Management and Evaluation Regions and Pv SystemsC.S.L. Behring GmbhSonglin XueExecutive Vice President and Global Head of PharmacovigilanceAstellas
- Elena YurenevaPrincipal Scientist, Clinical Safety & Risc ManagementMSDSyed ZaferuddinDeputy QPPVJamjoom PharmaceuticalsXiaofeng ZhouSenior Director, Epidemiology | Worldwide Safety and RegulatoryPfizer
- Sherry WinterProduct Marketing ManagerElsevier
WHO ATTENDS
A Unique Opportunity
We bring together the key players from the drug safety community, providing you with an unrivalled opportunity to expose and address the drug safety challenges facing your industry.
This is your perfect opportunity to demonstrate thought leadership and identify and approach new business prospects.
Get Involved At World Drug Safety Congress Americas
Organiser
